Thank you, Jardiance: Diabetes drug sales ease Boehringer’s patent-loss pain – FiercePharma

Thank you, Jardiance: Diabetes drug sales ease Boehringer’s patent-loss pain  FiercePharma

Strong sales from SGLT2 diabetes drug Jardiance in 2018 largely offset decreased sales from lung drug Spiriva for Boehringer Ingelheim. (Boehringer …